Tag: polygenic risk score
-
MyOme Unveils Polygenic Risk Score for Prostate Cancer
Introduction: A New Era in Prostate Cancer Risk Assessment MyOme, a leader in clinical whole-genome testing, has announced the launch of the first integrated polygenic risk score (PRS) for prostate cancer. This groundbreaking test goes beyond traditional screening by examining a broad array of genetic variants across the genome to identify hidden risk factors. The…
-
MyOme Unveils Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection
Overview: A New Era in Prostate Cancer Risk Assessment MyOme, a leading name in clinical whole-genome testing, has announced the launch of the first integrated polygenic risk score (PRS) for prostate cancer. This innovative approach combines a patient’s entire genome with sophisticated algorithms to estimate lifetime risk more precisely than traditional screening methods alone. The…
-
MyOme Unveils First Integrated Polygenic Risk Score for Prostate Cancer to Drive Early Detection and Personalized Prevention
Introduction: A New Era in Prostate Cancer Risk Assessment MyOme has introduced the first integrated polygenic risk score (PRS) for prostate cancer, packaged within its comprehensive whole-genome testing platform. This breakthrough combines multiple genetic signals across the genome to deliver a nuanced risk profile, going beyond traditional screening methods. The goal is to identify men…
-
Genetic Resilience to COPD: A Distinct Subtype in Smokers with High Genetic Risk
Understanding genetic resilience to COPD in smokers Chronic obstructive pulmonary disease (COPD) remains a major health challenge, yet not all smokers with a high genetic risk develop the condition. Recent research introduces a new concept: genetic resilience to COPD. By examining individuals who smoke and carry a high polygenic risk score (PRS) for COPD but…
-
Genetic Resilience: A Distinct COPD Subtype In Smokers With High Genetic Risk
Understanding Genetic Resilience in COPD COPD shows substantial variability in how it develops among people who smoke. While a genetic risk score helps predict who is more likely to develop COPD, many individuals with high genetic risk do not actually develop the disease. Recent research introduces the concept of genetic resilience to COPD—a clinically meaningful…
-
Genetic Resilience to COPD: A Distinct Subtype in Smokers
Understanding genetic resilience in COPD Cigarette smoking remains the leading environmental driver of chronic obstructive pulmonary disease (COPD), yet not all smokers develop the disease. Recent research introduces the concept of genetic resilience: individuals who carry a high genetic risk for COPD yet show no airflow obstruction. By studying this resilient group, scientists aim to…